Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Mar 18, 2025
Episode
267
Soundcloud
Share
This IASLC Virtual Tumor Board episode focuses on a patient with stage III ALK-positive NSCLC. ALK fusions are present in about 5% of NSCLC and there are now six ALK TKIs approved in the advanced setting. But how do we approach someone with earlier-stage disease?
Guest
Dwight Owen
MD
Associate Professor of Medicine
Ohio State University, James Comprehensive Cancer Center
Maria Lucia Reale
MD
Thoracic Medical Oncologist
Vito Fazzi Hospital of Lecce
